Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Premaitha - average down - buy

By HotStockRockets

11 October 2015 08:59

More:

Premaitha Health (NIPT) has announced an agreement with the leading distributor of scientific products in Greece (Antisel SA) to provide its IONA test to clinical laboratories in the region and that it has been informed that American company Illumina, Inc. has added a third patent to its suit against it. Buy, sell or hold?

Already a member? Sign in

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 13 year archive

• ShareProphets Daily Newsletter

Cancel any time

This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.

Comments

wildrides

11 October 2015, 14:27

Sell …………. it will lose in court .
Chris Standing

11 October 2015, 15:56

Umm, don’t what to do here, well down on this one at moment, my instincts tell me to average down, we’ii see how this price goes over the next few days, but I tend to feel that team Reynolds, know what they’re doing.
Hutch

12 October 2015, 11:41

TW, any chance of putting the Panmure note up for us to read? Cheers..
Captain Mainwaring

12 October 2015, 14:43

WILDRIDES – nonsense, Illumina are simply playing games as Premaitha have the superior product and the CE mark, plus Prem have beaten them at winning particular contracts. Illumina are well known for such antics and will NOT win in court.

This is a buying opportunity with re-rate to come. I’m with TW on this one.
wildrides

12 October 2015, 15:31

Captain
You would hardly expect the directors to issue an RNS saying “thats it guys were fecked” . Of course they are saying that the case will go their way . They want to collect their director fees until at least October 2016 . The market price is telling you that IIIlumina will lose or fail to make enough sales headway . If the case had no merit it would have been thrown out by now . Toms invested and probably a little above water still so you would expect him to be pro the share anyway .